PHILLIP FROST - 16 Jul 2021 Form 4 Insider Report for Cocrystal Pharma, Inc. (COCP)

Role: Director
Signature: /s/ Phillip Frost, MD, ET AL
Issuer symbol: COCP
Transactions as of: 16 Jul 2021
Net transactions value: $0
Form type: 4
Filing time: 20 Jul 2021, 16:05:30 UTC
Previous filing: 15 Jun 2021
Next filing: 16 Aug 2021
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	COCP	Stock Options (Right to Buy)	Award	$0	+65,000		$0.000000	65,000	16 Jul 2021	Common Stock	65,000	$1.11	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock options were issued pursuant to the 2015 Equity Incentive Plan and vest as follows: one-half will vest and become exercisable on July 16, 2022 and the remaining half will vest and become exercisable in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2022, subject to the reporting person continuing to serve as a director of the Company on each applicable vesting date.

Content

The stock options were issued pursuant to the 2015 Equity Incentive Plan and vest as follows: one-half will vest and become exercisable on July 16, 2022 and the remaining half will vest and become exercisable in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2022, subject to the reporting person continuing to serve as a director of the Company on each applicable vesting date.